These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34866834)

  • 21. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series.
    Kandan S; Thappa DM
    Indian J Dermatol Venereol Leprol; 2009; 75(4):373-8. PubMed ID: 19584462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide.
    Pandya AG; Sontheimer RD
    Arch Dermatol; 1992 Dec; 128(12):1626-30. PubMed ID: 1456758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
    Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
    Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
    Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
    Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Life-threatening course of pemphigus vulgaris complicated by sepsis caused by azathioprine-induced bone marrow suppression, successfully managed with combination therapy.
    Tichy M; Urbanek J; Sternbersky J; Ditrichova D; Hercogova J
    Dermatol Ther; 2014; 27(3):183-6. PubMed ID: 24283408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Exacerbation of Cough as a Precipitating Cause of Hypoxia in COVID-19 Patients.
    Kumar A; Kumar A; Kumar A; Sinha C; Kumar N; Singh PK
    Indian J Crit Care Med; 2021 Nov; 25(11):1324-1325. PubMed ID: 34866836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemphigus vulgaris involving the mouth and esophagus. Report of a case and review of the literature.
    Yamamoto H; Kozawa Y; Otake S; Shimokawa R
    Int J Oral Surg; 1983 Jun; 12(3):194-200. PubMed ID: 6411642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
    Jain R; Kumar B
    J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corona, Acute Ischemic Stroke, Malignant Cerebral Edema, and Hemo-adsorption: A Case Report.
    Shah M; Kaidawala Z; Shah A; Desphande R
    Indian J Crit Care Med; 2022 Feb; 26(2):235-238. PubMed ID: 35712732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second-degree Heart Block Caused by Itolizumab-induced Infusion Reaction in COVID-19.
    Kumar A; Kumar N; Lenin D; Kumar A; Ahmad S
    Indian J Crit Care Med; 2021 Apr; 25(4):474-475. PubMed ID: 34045820
    [No Abstract]   [Full Text] [Related]  

  • 31. Pemphigus vulgaris: an evidence-based treatment update.
    Zhao CY; Murrell DF
    Drugs; 2015 Feb; 75(3):271-84. PubMed ID: 25655250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pemphigus vulgaris in three adolescents: the course of the disease.
    Popadic S; Medenica L; Skiljevic D; Djakovic Z; Nikolic M
    Australas J Dermatol; 2011 Aug; 52(3):e3-7. PubMed ID: 21834807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual Oxygen Therapy in COVID-19 Patient: A Method to Improve Oxygenation.
    Kumar A; Kumar A; Sinha C; Kumar N; Singh K; Singh PK
    Indian J Crit Care Med; 2021 Feb; 25(2):231-233. PubMed ID: 33707906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
    Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
    Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients.
    Gheisari M; Faraji Z; Dadras MS; Nasiri S; Robati RM; Moravvej H; Tehranchinia Z; Ghalamkarpour F; Namazi N; Nobari NN
    Dermatol Ther; 2019 Sep; 32(5):e13057. PubMed ID: 31400243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Management of Malignancy-Exacerbated Pemphigus Vulgaris During COVID-19 Pandemic.
    Corrà A; Cammelli F; Quintarelli L; Barbato G; Le Rose O; Salemme A; Di Zenzo G; Coratti F; Verdelli A; Aimo C; Mariotti EB; Bianchi B; Cianchi F; Caproni M
    Front Med (Lausanne); 2021; 8():708284. PubMed ID: 34458285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-cytokine Therapy in Hospitalized Patients with COVID-19: The Jury is Out.
    Garg SK
    Indian J Crit Care Med; 2022 Oct; 26(10):1069-1071. PubMed ID: 36876195
    [No Abstract]   [Full Text] [Related]  

  • 38. Cutaneous Mucormycosis: A Fatal Complication of Immunosuppressant Therapy for Pemphigus Vulgaris.
    Sahni K; De D; Dogra S; Kanwar A; Saikia UN
    Skinmed; 2017; 15(6):467-469. PubMed ID: 29282189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigus in children.
    Kanwar AJ; Kaur S
    Int J Dermatol; 1991 May; 30(5):343-6. PubMed ID: 2066191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic pemphigus vulgaris of the gingiva. A case report with a 6-year follow-up.
    Orlowski WA; Bressman E; Doyle JL; Chasens AI
    J Periodontol; 1983 Nov; 54(11):685-9. PubMed ID: 6580422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.